Citi analyst Mathieu Chevrier upgraded Pro Medicus to Neutral from Sell with an unchanged price target of A$61. The analyst cites the recent decline in the shares for the upgrade.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PMCUF: